<unk>  is a hypoglycemic agent that is FDA approved for the treatment of type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia, headache, nausea, and dizziness.
Glimepiride
Liraglutide
Exenatide
Linagliptin
Repaglinide
Pioglitazone
Miglitol
Vildagliptin